Safety biomarker applications in drug development
نویسندگان
چکیده
منابع مشابه
Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
Advancing in genome sequencing has greatly propelled the understanding of the living world, however, it is insufficient for full description of a biological system. Focusing on, proteomics has emerged as another large-scale platform for improving the understanding of biology. Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomark...
متن کاملProteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
Advancing in genome sequencing has greatly propelled the understanding of the living world, however, it is insufficient for full description of a biological system. Focusing on, proteomics has emerged as another large-scale platform for improving the understanding of biology. Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomark...
متن کاملProteomics in biomarker discovery and drug development.
Proteomics is a research field aiming to characterize molecular and cellular dynamics in protein expression and function on a global level. The introduction of proteomics has been greatly broadening our view and accelerating our path in various medical researches. The most significant advantage of proteomics is its ability to examine a whole proteome or sub-proteome in a single experiment so th...
متن کاملLaser safety importance in clinical laser applications
Introduction: By introducing of laser systems and their continuous development, a new chapter of laser systems applications in a variety fields including research and clinical science in addition to the therapeutic, diagnostic applications were available for medical professionals in various fields. Most lasers emit radiation with intrinsic probable risks where in laser-tissue i...
متن کاملIdentification of Pharmacogenomic Biomarker Classifiers in Cancer Drug Development
Physicians need improved tools for selecting treatments for individual patients. Many syndromes traditionally viewed as individual diseases are heterogeneous in molecular pathogenesis and treatment responsiveness. This results in treatment of many patients with ineffective drugs and leads to the conduct of large clinical trials to identify small average treatment benefits for heterogeneous grou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Toxicological Sciences
سال: 2019
ISSN: 0388-1350,1880-3989
DOI: 10.2131/jts.44.225